🇺🇸 FDA
Pipeline program

Enoxaparin

ENOXA_C_01249

Approved small_molecule completed

Quick answer

Enoxaparin for Acute Illness is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Acute Illness
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials